(Q58107929)

https://api.crossref.org/works/10.1042%2FBJ20101062

Insulin-sensitive obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

The metabolically healthy but obese individual presents a favorable inflammation profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Are natural killer cells protecting the metabolically healthy obese patient?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Identification and characterization of metabolically benign obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

High adiponectin concentrations are associated with the metabolically healthy obese phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Cidea is associated with lipid droplets and insulin sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Regulation of inflammation-related genes in human adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Discrimination between obesity and insulin resistance in the relationship with adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Adipose tissue collagen VI in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

The AMP-activated protein kinase--fuel gauge of the mammalian cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

LKB1 deficiency in Tie2-Cre-expressing cells impairs ischemia-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

AMPK and SIRT1: a long-standing partnership?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

5-aminoimidazole-4-carboxamide ribonucleoside and AMP-activated protein kinase inhibit signalling through NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062

AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101062